Literature DB >> 27650103

Cell adhesion molecules are altered during irinotecan-induced mucositis: a qualitative histopathological study.

Noor Al-Dasooqi1, Joanne Bowen2, Colin Bennett2, John Finnie3,4, Dorothy Keefe5, Rachel Gibson2.   

Abstract

PURPOSE: Chemotherapy-induced mucositis is characterised by damage to mucous membranes throughout the alimentary tract. This study aims to investigate the expression of cell adhesion molecules (CAMs) following treatment with irinotecan.
METHODS: Dark agouti rats received a single dose of 175 mg/kg irinotecan and sacrificed at various time points after treatment. Picro-sirius red staining indicated an increase in collagen around crypts from 24 h in both small and large intestinal regions and this diminished at the later time points. CAMs E-cadherin, P-selectin, E-selectin and integrin-α1 were examined using immunohistochemistry.
RESULTS: E-cadherin was significantly elevated in jejunal crypts at the time of maximal tissue damage (48 h), while it decreased at the healing phase (96 h) in both jejunum and colon. P-selectin expression decreased significantly in the jejunum following irinotecan. Crypt expression of E-selectin was significantly elevated in the healing phase of mucositis (96 h). Integrin-α1 expression was significantly altered during the time course in the villus (p = 0.0032) and lamina propria (p = 0.039).
CONCLUSIONS: Irinotecan induced a significant alteration in CAM expression in the jejunum and colon. Changes in adhesion molecule expression may have a direct impact on the loss of mucosal layer integrity seen in mucositis.

Entities:  

Keywords:  Adhesion proteins; Alimentary tract; Chemotherapy; Histopathology; Mucositis

Mesh:

Substances:

Year:  2016        PMID: 27650103     DOI: 10.1007/s00520-016-3413-x

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  31 in total

1.  Irinotecan-induced alterations in intestinal cell kinetics and extracellular matrix component expression in the Dark Agouti rat.

Authors:  Noor Al-Dasooqi; Joanne M Bowen; Rachel J Gibson; Richard M Logan; Andrea M Stringer; Dorothy M Keefe
Journal:  Int J Exp Pathol       Date:  2011-04-05       Impact factor: 1.925

2.  Cytotoxic chemotherapy upregulates pro-apoptotic Bax and Bak in the small intestine of rats and humans.

Authors:  Joanne M Bowen; Rachel J Gibson; Dorothy M Keefe; Adrian G Cummins
Journal:  Pathology       Date:  2005-02       Impact factor: 5.306

3.  Updated clinical practice guidelines for the prevention and treatment of mucositis.

Authors:  Dorothy M Keefe; Mark M Schubert; Linda S Elting; Stephen T Sonis; Joel B Epstein; Judith E Raber-Durlacher; Cesar A Migliorati; Deborah B McGuire; Ronald D Hutchins; Douglas E Peterson
Journal:  Cancer       Date:  2007-03-01       Impact factor: 6.860

4.  Establishment of a single-dose irinotecan model of gastrointestinal mucositis.

Authors:  Rachel J Gibson; Joanne M Bowen; Enrique Alvarez; John Finnie; Dorothy M K Keefe
Journal:  Chemotherapy       Date:  2007-08-21       Impact factor: 2.544

Review 5.  Lessons learned from the irinotecan metabolic pathway.

Authors:  M K Ma; H L McLeod
Journal:  Curr Med Chem       Date:  2003-01       Impact factor: 4.530

6.  Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer.

Authors:  Rachel J Gibson; Joanne M Bowen; Mark R B Inglis; Adrian G Cummins; Dorothy M K Keefe
Journal:  J Gastroenterol Hepatol       Date:  2003-09       Impact factor: 4.029

Review 7.  Gastrointestinal mucositis: a new biological model.

Authors:  Dorothy M K Keefe
Journal:  Support Care Cancer       Date:  2003-11-05       Impact factor: 3.603

8.  Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis.

Authors:  Richard M Logan; Rachel J Gibson; Joanne M Bowen; Andrea M Stringer; Stephen T Sonis; Dorothy M K Keefe
Journal:  Cancer Chemother Pharmacol       Date:  2007-08-17       Impact factor: 3.333

Review 9.  The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs.

Authors:  Richard M Logan; Andrea M Stringer; Joanne M Bowen; Ann S-J Yeoh; Rachel J Gibson; Stephen T Sonis; Dorothy M K Keefe
Journal:  Cancer Treat Rev       Date:  2007-05-15       Impact factor: 12.111

Review 10.  MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.

Authors:  Rajesh V Lalla; Joanne Bowen; Andrei Barasch; Linda Elting; Joel Epstein; Dorothy M Keefe; Deborah B McGuire; Cesar Migliorati; Ourania Nicolatou-Galitis; Douglas E Peterson; Judith E Raber-Durlacher; Stephen T Sonis; Sharon Elad
Journal:  Cancer       Date:  2014-02-25       Impact factor: 6.860

View more
  1 in total

1.  Mouse organoids as an in vitro tool to study the in vivo intestinal response to cytotoxicants.

Authors:  F Jardi; C Kelly; C Teague; H Fowler-Williams; D C Sevin; D Rodrigues; H Jo; S Ferreira; B Herpers; M Van Heerden; T de Kok; C Pin; A Lynch; C A Duckworth; S De Jonghe; L Lammens; D M Pritchard
Journal:  Arch Toxicol       Date:  2022-10-06       Impact factor: 6.168

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.